Total raised
—
Last: Pre-Seed 2021-12
Stage
Pre-Seed
Founded
2021
Headcount
6
HQ
Ness Ziona
Sector
Health Tech & Life Sciences
About
CatchMe Therapeutics develops a solution for specific inhibition based on the in vivo biological binding preference of targeted proteins. The company's versatile platform can be expanded to target different methyl binding proteins and different indications.
Funding history · 1 round · — total
2021-12
Pre-Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesPatientsLife SciencesBiotechnologyPharmaceuticals
Business model
B2B
Tags
proteinsdrug-developmenthospitalspharmaceuticalscancer-therapy